A Study of the Enzyme Activity and Safety of Pancrelipase in Patients With Severe Exocrine Pancreatic Insufficiency (EPI)

NCT00676702 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Exocrine Pancreatic Insufficiency
Pancreatitis, Chronic
Steatorrhea
Pancreatitis

Interventions

DIETARY_SUPPLEMENT: Ensure Plus
DRUG: Pancrelipase in combination with Ensure Plus

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.